通过皮肤进行冠状动脉干预后,系统性硬化症患者的长期心血管结果
Kazutoshi Hirose1, Hiroyuki Kiriyama1, Shun Minatsuki1
1Department of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
International journal of cardiology. Heart & vasculature
|February 24, 2025
概括
冠状动脉疾病 (CAD) 的全身性硬化症 (SSc) 患者在皮肤冠状动脉干预 (PCI) 后经历了更糟糕的长期心血管结果. 这项研究突出显示,在PCI后的SSc患者中,CAD复杂性和不良事件增加.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 血管医学 血管医学
背景情况:
- 系统性硬化症 (SSc) 与冠状动脉疾病 (CAD) 风险增加和较差的结果有关.
- 在SSc患有CAD的患者中,形态特征和长期心血管结果尚不清楚.
研究的目的:
- 研究患有同时SSc和CAD的患者的特征和长期心血管结果.
- 为了比较经皮冠状动脉干预 (PCI) 的SSc和非SSc患者之间的CAD复杂性和临床结果.
主要方法:
- 对接受PCI的3300名CAD患者进行了回顾性分析.
- 倾向性得分匹配 (1:3) 比较SSc (n=17) 和非SSc (n=51) 组.
- 分析包括实验室,心声学,血管学数据和临床结果 (心脏死亡,心肌梗塞,中风,心力衰竭住院).
主要成果:
- 两组实验室或心声学参数之间没有显著差异.
- 在SSc组中,CAD显示出更大的复杂性趋势,包括左侧主干病变和更高的SYNTAX分数.
- 在随访期间,SSc患者出现了明显更多的初级 (心脏病死亡,心脏病发作,中风) 和二次 (初级结局 + HF住院) 副作用.
结论:
- 患有CAD和SSc的患者在PCI后的长期心血管结果较差,与没有SSc的患者相比.
- SSc与更复杂的冠状动脉疾病和PCI后心血管不良事件增加有关.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...